{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:54Z","timestamp":1793327454608,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canlet.2026.218916","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:10:32Z","timestamp":1792537832000},"page":"218916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CDK9 degradation suppresses gastroesophageal cancer growth and overcomes radiation resistance through chromatin remodeling and YAP1\/TEAD downregulation"],"prefix":"10.1016","volume":"662","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-9021","authenticated-orcid":false,"given":"Yan-ting Yann","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Ghelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6625-704X","authenticated-orcid":false,"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2841-5518","authenticated-orcid":false,"given":"Haiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Calendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Generosa","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Athavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-156X","authenticated-orcid":false,"given":"Curt","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonbok","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Khazak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.canlet.2026.218916_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study","volume":"4","author":"Global Burden of Disease Cancer","year":"2018","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218916_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.canlet.2026.218916_bib3","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.3748\/wjg.v19.i34.5598","article-title":"Epidemiology of esophageal cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218916_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.678559","article-title":"CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents","volume":"11","author":"Anshabo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218916_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116470","article-title":"CDK9 inhibitors for the treatment of solid tumors","volume":"229","author":"Mo","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218916_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41416-024-02810-8","article-title":"CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer","volume":"131","author":"Rahman","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218916_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.09.051","article-title":"Targeting CDK9 reactivates epigenetically silenced genes in cancer","volume":"175","author":"Zhang","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-023-01762-6","article-title":"CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma","volume":"22","author":"Thieme","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218916_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092181","article-title":"Targeting CDK9 for anti-cancer therapeutics","volume":"13","author":"Mandal","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.canlet.2026.218916_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028753","article-title":"Cell junctions in hippo signaling","volume":"10","author":"Karaman","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218916_bib11","first-page":"2495","article-title":"Hippo-YAP signaling in digestive system tumors","volume":"11","author":"Yin","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.molcel.2015.09.001","article-title":"YAP drives growth by controlling transcriptional pause release from dynamic enhancers","volume":"60","author":"Galli","year":"2015","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib13","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1038\/s41467-025-59309-w","article-title":"The mechanism of YAP\/TAZ transactivation and dual targeting for cancer therapy","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020293","article-title":"The Renaissance of Cyclin dependent kinase inhibitors","volume":"14","author":"Ettl","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.canlet.2026.218916_bib15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1078-0432.CCR-19-1853","article-title":"AZD4573 is a highly selective CDK9 inhibitor that suppresses MCL-1 and induces apoptosis in hematologic cancer cells","volume":"26","author":"Cidado","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218916_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.18632\/oncotarget.28473","article-title":"CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies","volume":"14","author":"Morillo","year":"2023","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2026.218916_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.canlet.2026.218916_bib18","doi-asserted-by":"crossref","first-page":"14129","DOI":"10.1021\/acs.jmedchem.5c01818","article-title":"NDA submission of vepdegestrant (ARV-471) to U.S. FDA: the beginning of a new era of PROTAC degraders","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2219470","article-title":"Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments","volume":"24","author":"Xiao","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13046-021-02003-8","article-title":"Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma","volume":"40","author":"Song","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-17-0560","article-title":"A novel YAP1 inhibitor targets CSC-enriched radiation-resistant cells and exerts strong antitumor activity in esophageal adenocarcinoma","volume":"17","author":"Song","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"issue":"17","key":"10.1016\/j.canlet.2026.218916_bib22","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1158\/0008-5472.CAN-09-4474","article-title":"Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation","volume":"70","author":"Si","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218916_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genom. Proteom. Bioinform."},{"issue":"3","key":"10.1016\/j.canlet.2026.218916_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10620-022-07586-6","article-title":"Lymphatic drainage system and lymphatic metastasis of cancer cells in the mouse esophagus","volume":"68","author":"Li","year":"2023","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.canlet.2026.218916_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/abbs\/gmr042","article-title":"Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells","volume":"43","author":"Zhang","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"10","key":"10.1016\/j.canlet.2026.218916_bib26","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jcb.24587","article-title":"Formation of cofilin-actin rods following cucurbitacin-B-induced actin aggregation depends on slingshot homolog 1-mediated cofilin hyperactivation","volume":"114","author":"Zhang","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"17","key":"10.1016\/j.canlet.2026.218916_bib27","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.canlet.2026.218916_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf018","article-title":"edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets","volume":"53","author":"Chen","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218916_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.canlet.2026.218916_bib31","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.canlet.2026.218916_bib32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.canlet.2026.218916_bib33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","article-title":"Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.canlet.2026.218916_bib34","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/0008-5472.CAN-13-3569","article-title":"Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties","volume":"74","author":"Song","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218916_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1878-0261.12667","article-title":"Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma","volume":"14","author":"Song","year":"2020","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218916_bib36","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-18-1029","article-title":"YAP1-Mediated CDK6 activation confers radiation resistance in esophageal cancer - rationale for the combination of YAP1 and CDK4\/6 inhibitors in esophageal cancer","volume":"25","author":"Li","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031864","article-title":"Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cc.10.1.14364","article-title":"A role for CDK9-cyclin K in maintaining genome integrity","volume":"10","author":"Yu","year":"2011","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.canlet.2026.218916_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/jcb.26293","article-title":"CDK9: a key player in cancer and other diseases","volume":"119","author":"Franco","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218916_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gutjnl-2019-319748","article-title":"YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition","volume":"70","author":"Ajani","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.canlet.2026.218916_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.15698\/cst2021.11.258","article-title":"Mechanisms of YAP\/TAZ transcriptional control","volume":"5","author":"Battilana","year":"2021","journal-title":"Cell Stress"},{"issue":"9","key":"10.1016\/j.canlet.2026.218916_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41419-023-06157-5","article-title":"RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer","volume":"14","author":"Prokakis","year":"2023","journal-title":"Cell Death Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:37:31Z","timestamp":1793324251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0304383526006804"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218916","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDK9 degradation suppresses gastroesophageal cancer growth and overcomes radiation resistance through chromatin remodeling and YAP1\/TEAD downregulation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218916"}}